The effect of dialysis modality on phosphate control: Haemodialysis compared to haemodiafiltration. the Pan Thames Renal Audit

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 897-901

  Davenport, Andrew ^a   Gardner, Carrie ^b   Delaney, Michael ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Audit Commission   (United Kingdom)

^c EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Calcium; Guidelines; Haemodiafiltration; Haemodialysis; Phosphate

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; DIALYSIS; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; CALCIUM; CLINICAL AUDIT; FEMALE; HEMODIAFILTRATION; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77649230089     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp560     Document Type: Article

References (30)

1. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
2. Kalantar-Zadeh K, Kovesdy CP, Derose SF, et al. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 2007; 3: 493-506 (Pubitemid 47313025)
3. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
4. Sugisaki H, Onohara M, Kunitomo T. Dynamic behavior of plasma phosphate in chronic dialysis patients. Trans Am Soc Artif Intern Organs 1982; 28: 302-307
5. www.kidney.org/professionals/kdoqi/guidelines-bone/index.htm
6. Renal Association Clinical practice guidelines. 4th Ed. Module 2, complications. www.renal.org/guidelines 2007
7. Gallar P, Ortiz M, Ortega O, et al. Factors which influence phosphorus removal in hemodialysis. Nefrologia 2007; 27: 46-52
8. Albalate C, Fernandez MD, Lopez C, et al. Can we increase phosphate removal with conventional hemodialysis? Nefrologia 2003; 23: 520-527
9. Gutzwiller JP, Schneiditz D, Huber AR, et al. Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Clinic Nephrol 2003; 59: 130-136
10. Leypoldt JK. Kinetics of [2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Semin Dial 2005; 18: 401-408
11. Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int 1993; 41: S245-S251
12. Pieratos A, Owendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998; 9: 859-868
13. Toussaint N, Boddington J, Simmonds R, et al. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial Int 2006; 10: 280-286
14. Zehnder C, Gutzwiller JP, Renggli K. Hemodiafiltration-a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 1999; 52: 152-159
15. Bolasco PG, Ghezzi PM, Ferrara R, et al. Effect of on-line haemodia-filtration with endogenous reinfusion (HFR) on the calcium phosphorous metabolism: medium term effects. Int J Artif Organs 2006; 29: 1042-1052
16. Vaslaki L, Major L, Berta K, et al. On-line haemodiafiltration versus haemodialysis: stable hematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006; 24: 163-173
17. Angelis M, Wong LL, Myers SA, et al. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 1997; 122: 1083-1089
18. Ketteler M, Floege J. Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes. Nephrol Dial Transplant 2006; 21: 33-35
19. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006; 70: 351-357
20. Tentori F, Hunt WC, Rohrscheib M, et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organisation. J Am Soc Nephrol 2007; 18: 2377-2384
21. Morey B, Walker R, Davenport A. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract 2008; 109: c173-c180
22. Davenport A. Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous hemofiltration and/or hemodiafiltration. Contrib Nephrol 2004; 144: 317-328
23. Covic A, Goldsmith DJ. Final Word: The binders wars 2007-2017: "The truth is out there somewhere". Semin Dial 2007; 20: 170-171
24. Davenport A, Goel S, MacKenzie JC. Audit of the use of calcium carbonate as a phosphate binder in 100 patients treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1992; 7: 632-635
25. Young EW, Akiba T, Albert JM, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44(Suppl 3): 34-38
26. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61: 655-657
27. Gura V, Davenport A, Beizai M, et al. β2 Microglobulin and phosphate clearances using a wearable artificial kidney: pilot study. Am J Kidney Dis 2009; 54: 104-111
28. Henderson LW, Colton CK, Ford CA. Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med 1975; 85: 372-391
29. Bianchi ML, Soldati L, Giaretto S, et al. Biofiltration and calcium-phosphate metabolism. Int J Artif Organs 1986; 9(Suppl 3): S51-S54
30. Zehnder C, Gutzwiller JP, Renggli K. Hemodiafiltration-a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 1999; 52: 152-159